Compugen (CGEN) Treasury Shares (2024 - 2025)
Compugen's (CGEN) quarterly Treasury Shares came in at $567400.0 in Q4 2025, up 78.79% year-on-year from $317350.0 in Q4 2024, and up 78.79% quarter-over-quarter from $317350.0 in Q4 2024.
Compugen (CGEN) Treasury Shares (2024 - 2025) Analysis & Trends
Compugen has disclosed Treasury Shares across 2 years of filings, most recently posting $567400.0 for Q4 2025.
- Treasury Shares for Q4 2025 came in at $567400.0, up 78.79% year-over-year; the trailing twelve-month figure through Dec 2025 was $567400.0 (up 78.79% YoY), and the FY2025 annual result was $567400.0, up 78.79% from the prior year.
- Treasury Shares came in at $567400.0 for Q4 2025 at Compugen, up from $317350.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $567400.0 in Q4 2025 to a low of $317350.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 567,400.00 |
| Dec 31, 2025 | 567,400.00 |
| Dec 31, 2024 | 317,350.00 |
| Dec 31, 2024 | 317,350.00 |